Rapamycin, a novel macrolide immunosuppressant, inhibits mTOR-induced CD8+ T cells in the lung tissue of a mouse emphysema model exposed to chronic cigarette smoke35. The gene discussed is CD8A; the disease is pulmonary emphysema.